Showing 1 - 2 results of 2 for search 'Chufeng Ding', query time: 0.01s Refine Results
  1. 1
    Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system

    Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system by Chufeng Ding, Lin Ma, Yankun Liang, Zhenpo Zhang, Qimin Wu, Jun Lyu, Ling Su

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database

    Hematologic and lymphatic disorders associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) databas... by Zhenpo Zhang, Jingping Zheng, Yankun Liang, Qimin Wu, Chufeng Ding, Lin Ma, Ling Su

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: